(Q35578572)

9 August 2017

1 reference

title

Graft-versus-host disease, the graft-versus-leukemia effect, and mixed chimerism following nonmyeloablative stem cell transplantation (English)

1 reference

9 August 2017

Graft-versus-Host Disease, the Graft-versus-Leukemia Effect, and Mixed Chimerism following Nonmyeloablative Stem Cell Transplantation (English)

1 reference

29 March 2024

author name string

Shimon Slavin

series ordinal

1

1 reference

9 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14604277

29 March 2024

publication date

1 October 2003

1 reference

full work available at URL

9 August 2017

http://link.springer.com/article/10.1007/BF02983795/fulltext.html

1 reference

http://link.springer.com/content/pdf/10.1007/BF02983795.pdf

29 March 2024

file format

Portable Document Format

1 reference

http://link.springer.com/content/pdf/10.1007/BF02983795

29 March 2024

1 reference

International Journal of Hematology

29 March 2024

published in

1 reference

9 August 2017

volume

78

1 reference

9 August 2017

issue

3

1 reference

9 August 2017

page(s)

195-207

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02983795

9 August 2017

exact match

0 references

cites work

Ultrastructural, cell membrane, and cytogenetic characteristics of B-cell leukemia, a murine model of chronic lymphocytic leukemia

1 reference

12 December 2020

Generation of donor-derived antileukemic cytotoxic T-lymphocyte responses for treatment of relapsed leukemia after allogeneic HLA-identical bone marrow transplantation.

1 reference

12 December 2020

Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation

1 reference

12 December 2020

Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation

1 reference

12 December 2020

Use of recombinant human interleukin-2 in conjunction with bone marrow transplantation as a model for control of minimal residual disease in malignant hematological disorders: I. Treatment of murine leukemia in conjunction with allogeneic bone marro

1 reference

12 December 2020

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

12 December 2020

Rituximab: the first monoclonal antibody approved for the treatment of lymphoma

1 reference

12 December 2020

The CAMPATH-1 antigen (CDw52)

1 reference

12 December 2020

Characterization of effector cells of graft vs leukemia following allogeneic bone marrow transplantation in mice inoculated with murine B-cell leukemia

1 reference

12 December 2020

Transplantation of allogeneic bone marrow without graft-versus-host disease using total lymphoid irradiation

1 reference

12 December 2020

Low intensity regimens with allogeneic hematopoietic stem cell transplantation as treatment of hematologic neoplasia.

1 reference

12 December 2020

Spontaneous murine B-cell leukaemia

1 reference

12 December 2020

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients

1 reference

12 December 2020

A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes

1 reference

12 December 2020

Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.

1 reference

12 December 2020

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

1 reference

12 December 2020

Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia

1 reference

12 December 2020

Karnofsky Memorial Lecture. Marrow transplantation for malignant diseases

1 reference

12 December 2020

Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity

1 reference

12 December 2020

Fludarabine-based protocol for human umbilical cord blood transplantation in children with Fanconi anemia

1 reference

12 December 2020

Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines

1 reference

12 December 2020

Durable complete remission of acute nonlymphocytic leukemia associated with discontinuation of immunosuppression following relapse after allogeneic bone marrow transplantation. A case report of a probable graft-versus-leukemia effect

1 reference

12 December 2020

Immunotherapy of cancer with alloreactive lymphocytes

1 reference

12 December 2020

The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation

1 reference

12 December 2020

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

1 reference

12 December 2020

Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy

1 reference

12 December 2020

Donor lymphocyte infusions to displace residual host hematopoietic cells after allogeneic bone marrow transplantation for beta-thalassemia major

1 reference

12 December 2020

Immunotherapy of relapsed resistant chronic myelogenous leukemia post allogeneic bone marrow transplantation with alloantigen pulsed donor lymphocytes

1 reference

12 December 2020

T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse

1 reference

12 December 2020

Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes

1 reference

12 December 2020

Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease

1 reference

12 December 2020

Long-term survival of skin allografts in mice treated with fractionated total lymphoid irradiation

1 reference

12 December 2020

Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation

1 reference

12 December 2020

A pilot study of low-dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation

1 reference

12 December 2020

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

12 December 2020

Reinduction of remission of chronic myeloid leukemia by donor leukocyte transfusion following relapse after bone marrow transplantation: recovery complicated by initial pancytopenia and late dermatomyositis

1 reference

12 December 2020

Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease

1 reference

12 December 2020

Graft-versus-leukemia reactions after bone marrow transplantation

1 reference

12 December 2020

Improved single-step PCR assay for sex identification post-allogeneic sex-mismatched BMT.

1 reference

12 December 2020

Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection. The depletion of T cell subsets in vitro and in vivo.

1 reference

12 December 2020

Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer

1 reference

12 December 2020

Allogeneic cell-mediated immunotherapy for breast cancer after autologous stem cell transplantation: a clinical pilot study

1 reference

12 December 2020

Effect of cyclosporine A and methylprednisolone on the graft-versus-leukemia effects across major histocompatibility barriers in mice following allogeneic bone marrow transplantation

1 reference

12 December 2020

Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer

1 reference

12 December 2020

A fludarabine-based protocol for bone marrow transplantation in Fanconi's anemia

1 reference

12 December 2020

Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia

1 reference

12 December 2020

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

12 December 2020

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

12 December 2020

Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia

1 reference

12 December 2020

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

12 December 2020

Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer

1 reference

12 December 2020

Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse

1 reference

12 December 2020

Kettering Award Lecture. The role of marrow transplantation in the eradication of malignant disease.

1 reference

12 December 2020

Remission of relapsed leukaemia during a graft-versus-host reaction. A "graft-versus-leukaemia reaction" in man?

1 reference

12 December 2020

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation

1 reference

12 December 2020

Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells

1 reference

12 December 2020

Time pattern of the antileukemic effect of graft-versus-host reaction in mice.

1 reference

12 December 2020

Anti-tumor effects of allogeneic bone marrow transplantation in (NZB X NZW)F1 hybrids with spontaneous lymphosarcoma

1 reference

12 December 2020

Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells.

1 reference

12 December 2020

Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2

1 reference

12 December 2020

Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease

1 reference

12 December 2020

Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms

1 reference

12 December 2020

Establishment of anti-Epstein-Barr virus (EBV) cellular immunity by adoptive transfer of virus-specific cytotoxic T lymphocytes from an HLA-matched sibling to a patient with severe chronic active EBV infection.

1 reference

12 December 2020

Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation

1 reference

12 December 2020

Possibility of graft-vs-leukemia determinants independent of the major histocompatibility complex in allogeneic marrow transplantation

1 reference

12 December 2020

Bone marrow transplantation from a cadaveric donor

1 reference

12 December 2020

Mini-allografts: ongoing trials in humans

1 reference

12 December 2020

Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation

1 reference

12 December 2020

Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect.

1 reference

12 December 2020

Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1).

1 reference

12 December 2020

Total lymphoid irradiation

1 reference

12 December 2020

Allogeneic cell therapy for a murine mammary carcinoma

1 reference

12 December 2020

Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma

1 reference

12 December 2020

Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro

1 reference

12 December 2020

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

12 December 2020

Induction of graft vs. tumor effect in a murine model of mammary adenocarcinoma

1 reference

12 December 2020

Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients

1 reference

12 December 2020

Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases

1 reference

12 December 2020

Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis

1 reference

12 December 2020

Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo

1 reference

12 December 2020

13

31

1140

M Boranic

1971

1 reference

29 March 2024

22

58

3891

S Morecki

1998

1 reference

29 March 2024

64

41

4162

S Slavin

1981

1 reference

29 March 2024

Identifiers

DOI

10.1007/BF02983795

1 reference

9 August 2017

1 reference